Nicollet Investment Management’s Novo Nordisk NVO Stock Holding History

Nicollet Investment Management’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.39M	Sell	36,721 -2,175	-6%	-$100K	0.41%	50
2026 Q2	$1.86M	Sell	38,896 -309	-0.8%	-$13.3K	0.58%	45
2026 Q1	$1.44M	Buy	39,205 +18,633	+91%	+$883K	0.49%	49
2025 Q4	$1.05M	Sell	20,572 -18,141	-47%	-$928K	0.33%	53
2025 Q3	$2.15M	Sell	38,713 -1,125	-3%	-$65.9K	0.7%	37
2025 Q2	$2.75M	Sell	39,838 -2,124	-5%	-$144K	0.92%	32
2025 Q1	$2.91M	Buy	41,962 +1,341	+3%	+$111K	1.02%	34
2024 Q4	$3.49M	Sell	40,621 -632	-2%	-$68.3K	1.2%	29
2024 Q3	$4.91M	Buy	41,253 +58	+0.1%	+$7.74K	1.7%	22
2024 Q2	$5.88M	Sell	41,195 -571	-1%	-$75.7K	2.2%	13
2024 Q1	$5.36M	Buy	41,766 +76	+0.2%	+$9.05K	1.98%	17
2023 Q4	$4.31M	Sell	41,690 -284	-0.7%	-$28.1K	1.76%	21
2023 Q3	$3.82M	Buy	41,974 +396	+1%	+$34.9K	1.71%	20
2023 Q2	$3.36M	Buy	+41,578	New	+$3.4M	1.5%	24

Other funds holding NVO

EPAM

Euro Pacific Asset Management Dorado, Puerto Rico $1.22B AUM 22.48% 1-Year Est. Return

NPA

Nichols & Pratt Advisers Boston, Massachusetts $1.68B AUM 20.22% 1-Year Est. Return

GuoLine Advisory Singapore $1.16B AUM 31.35% 1-Year Est. Return

CFIA

Cantor Fitzgerald Investment Advisors New York $1.47B AUM 20.15% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

VFM

Viking Fund Management Minot, North Dakota $1.14B AUM 32.65% 1-Year Est. Return

ERP

Eldred Rock Partners San Antonio, Texas $451M AUM 38.39% 1-Year Est. Return

Atria Investments Charlotte, North Carolina $10.3B AUM 19.62% 1-Year Est. Return

BIAS

Beacon Investment Advisory Services Morristown, New Jersey $2.66B AUM 29.77% 1-Year Est. Return

MCP

Martin Capital Partners Eugene, Oregon $279M AUM 18.87% 1-Year Est. Return

Nicollet Investment Management's NVO Position: Q3 2026 in Review

Nicollet Investment Management reduced its Novo Nordisk (NVO) stake by 5.6% in Q3 2026, selling an estimated $100K and leaving 36,721 shares worth $1.39M. The position accounts for 0.41% of the portfolio, ranked #50.

Nicollet Investment Management first reported a position in NVO in Q2 2023 and has held it in 14 quarters since. The position peaked at $5.88M in Q2 2024. 165 funds tracked by Wall St. Rank hold NVO as of Q3 2026.

Nicollet Investment Management held 36,721 shares of Novo Nordisk worth $1.39M as of Q3 2026.
Nicollet Investment Management sold 2,175 Novo Nordisk shares in Q3 2026, an estimated $100K.
Novo Nordisk made up 0.41% of Nicollet Investment Management's portfolio in Q3 2026, its #50 holding.
Nicollet Investment Management first reported a position in Novo Nordisk in Q2 2023 and has held it in 14 quarters since.
Nicollet Investment Management's Novo Nordisk position peaked at $5.88M in Q2 2024.
165 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2026.

Based on Nicollet Investment Management's 13F filing for Q3 2026, filed 14 Oct 2026.